Low Lymphoma White Blood Cell Count & Lymphoma Symptoms

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster than they should. It is a moderately rare form of cancer, but prognoses are often fairly good.

Lymphoma White Blood Cell Count - Causes

The ultimate underlying causes of lymphoma, as with most cancers, are not fully understood. There may be genetic as well as environmental factors, and things that trigger the disease in some people may have no effect on others. At some point, however, a lymphocyte (usually a B-cell) will form that does not die when it should, but instead continues to divide and multiply until the abnormal, cancerous cells outnumber the healthy cells. This manifests the first and primary symptom of lymphoma, swollen lymph nodes.

Symptoms

The lymph nodes are locations within the lymphatic system that serve to collect and process lymphocytes. As the cancerous cells multiply in one of these nodes, they cause it to swell. This is typically not accompanied by pain, and can usually be detected by touch before the appearance of any other symptoms. Low white blood cell count and lymphoma symptoms often go hand in hand.

Such secondary symptoms can include the following:

  • Fever
  • Night sweats
  • Itching
  • Weight loss
  • Loss of appetite
  • Nausea and vomiting
  • Abdominal pain or constipation
  • Shortness of breath

Diagnosis: Does Lymphoma Cause Low White Blood Cell Count?

Because swollen lymph nodes can be caused by other things, including infection or even stress, it may be necessary for a doctor to run a series of blood tests, including determining a white blood cell count. It may also be necessary to take a CT scan to isolate the affected areas, or to biopsy the node to determine the type of lymphoma present. Treatment will be based on the results of these tests.

Treatment

The most common treatment for lymphoma is chemotherapy, but this might differ based on the type of lymphoma and the speed at which it is spreading. Low-grade or slow-growing cancers can typically be addressed with a single chemotherapy drug, but high- or intermediate-grade, fast-growing varieties may necessitate a combination of agents.

Chemotherapy carries its own side effects, including lowered amounts of bone marrow, where blood cells are usually created. Because of this, it may be beneficial to remove some marrow stem cells before chemotherapy begins and re-implant them afterward to compensate for the damage done by chemotherapy.

Another option is radiation therapy, which can be effective for localized or widespread cancerous involvement, but again carries its own risks. Chief among these is the suppression of the immune system, including low white blood cell count. This makes a person more susceptible to infection and can increase the risk of life-threatening hemorrhaging.

Conclusion

Oncologists will be able to help people choose a course of treatment and will help answer any questions the patient might have. Hearing that one has lymphoma or any cancer, can be a terrifying experience, but treatments are becoming more effective every day and many cancer patients can expect to live long and healthy lives after diagnosis.

Photo: Pexels

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap